Biogen Idec Ltd

Nusinersen is sold under the brand name Spinraza

$2,500.00 USD

~~$5,000.00 USD~~ $2,500.00 USD

Sale Sold out

Taxes included. Shipping calculated at checkout.

Drug form 液体

Quantity

Nusinersen Sodium Injection is a spinal muscular atrophy (SMA) treatment drug developed by Biogen Idec Ltd. It was first approved in the United States on December 23, 2016. It is the world's first SMA precision targeted treatment drug. The drug is administered by intrathecal injection, which can directly deliver the drug to the cerebrospinal fluid around the spinal cord, thereby improving motor function, increasing survival rate, and changing the disease process of SMA.

Specifications: 12MG/5ML

Manufacturer: Biogen original factory

Because the drug needs to be cold-chained throughout the process, please consult before placing an order